Mavik en es it fr

Mavik Brand names, Mavik Analogs

Mavik Brand Names Mixture

  • No information avaliable

Mavik Chemical_Formula

C20H27NO3

Mavik RX_link

No information avaliable

Mavik fda sheet

Mavik msds (material safety sheet)

Mavik Synthesis Reference

No information avaliable

Mavik Molecular Weight

329.433 g/mol

Mavik Melting Point

264 oC

Mavik H2O Solubility

No information avaliable

Mavik State

Solid

Mavik LogP

2.635

Mavik Dosage Forms

Capsules

Mavik Indication

Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.

Mavik Pharmacology

Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland. This product was withdrawn from the U.S. market in April 1994.

Mavik Absorption

No information avaliable

Mavik side effects and Toxicity

Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.

Mavik Patient Information

No information avaliable

Mavik Organisms Affected

Humans and other mammals